Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kligman plus methimazole versus Kligman alone for melasma
IRCT20200817048437N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methimazole in melasma (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: MASI score, Patient satisfaction and 1 more. Started Sep 2020; status: completed.
02
Drugs
methimazole
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20200817048437N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200817048437N1.